Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
| # | Name | Date |
|---|---|---|
| 1 | 202517048900-STATEMENT OF UNDERTAKING (FORM 3) [21-05-2025(online)].pdf | 2025-05-21 |
| 2 | 202517048900-REQUEST FOR EXAMINATION (FORM-18) [21-05-2025(online)].pdf | 2025-05-21 |
| 3 | 202517048900-PROOF OF RIGHT [21-05-2025(online)].pdf | 2025-05-21 |
| 4 | 202517048900-POWER OF AUTHORITY [21-05-2025(online)].pdf | 2025-05-21 |
| 5 | 202517048900-FORM 18 [21-05-2025(online)].pdf | 2025-05-21 |
| 6 | 202517048900-FORM 1 [21-05-2025(online)].pdf | 2025-05-21 |
| 7 | 202517048900-DECLARATION OF INVENTORSHIP (FORM 5) [21-05-2025(online)].pdf | 2025-05-21 |
| 8 | 202517048900-COMPLETE SPECIFICATION [21-05-2025(online)].pdf | 2025-05-21 |
| 9 | 202517048900-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [21-05-2025(online)].pdf | 2025-05-21 |
| 10 | 202517048900-RELEVANT DOCUMENTS [03-06-2025(online)].pdf | 2025-06-03 |
| 11 | 202517048900-MARKED COPIES OF AMENDEMENTS [03-06-2025(online)].pdf | 2025-06-03 |
| 12 | 202517048900-FORM 13 [03-06-2025(online)].pdf | 2025-06-03 |
| 13 | 202517048900-AMMENDED DOCUMENTS [03-06-2025(online)].pdf | 2025-06-03 |
| 14 | 202517048900-FORM 3 [31-10-2025(online)].pdf | 2025-10-31 |